Compare with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANG LIFESCIENCES INDIA vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ANG LIFESCIENCES INDIA WOCKHARDT ANG LIFESCIENCES INDIA/
WOCKHARDT
 
P/E (TTM) x - -107.2 - View Chart
P/BV x 9.2 1.4 652.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ANG LIFESCIENCES INDIA   WOCKHARDT
EQUITY SHARE DATA
    ANG LIFESCIENCES INDIA
Mar-21
WOCKHARDT
Mar-21
ANG LIFESCIENCES INDIA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs46570 8.0%   
Low Rs13174 7.6%   
Sales per share (Unadj.) Rs298.0249.3 119.5%  
Earnings per share (Unadj.) Rs13.662.2 21.8%  
Cash flow per share (Unadj.) Rs16.184.4 19.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs80.3302.3 26.6%  
Shares outstanding (eoy) m5.18110.78 4.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.11.5 6.6%   
Avg P/E ratio x2.26.0 36.3%  
P/CF ratio (eoy) x1.84.4 41.4%  
Price / Book Value ratio x0.41.2 29.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m15241,188 0.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1287,630 1.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,54427,620 5.6%  
Other income Rs m61,534 0.4%   
Total revenues Rs m1,54929,155 5.3%   
Gross profit Rs m14612,575 1.2%  
Depreciation Rs m132,460 0.5%   
Interest Rs m372,491 1.5%   
Profit before tax Rs m1019,159 1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m312,273 1.4%   
Profit after tax Rs m706,886 1.0%  
Gross profit margin %9.545.5 20.8%  
Effective tax rate %30.724.8 123.7%   
Net profit margin %4.624.9 18.3%  
BALANCE SHEET DATA
Current assets Rs m1,15924,244 4.8%   
Current liabilities Rs m91631,182 2.9%   
Net working cap to sales %15.7-25.1 -62.7%  
Current ratio x1.30.8 162.8%  
Inventory Days Days930 28.8%  
Debtors Days Days138,887,47512 1,145,310,156.5%  
Net fixed assets Rs m27849,508 0.6%   
Share capital Rs m52554 9.4%   
"Free" reserves Rs m36432,939 1.1%   
Net worth Rs m41633,492 1.2%   
Long term debt Rs m705,029 1.4%   
Total assets Rs m1,43773,752 1.9%  
Interest coverage x3.74.7 79.8%   
Debt to equity ratio x0.20.2 112.6%  
Sales to assets ratio x1.10.4 287.0%   
Return on assets %7.512.7 58.8%  
Return on equity %16.920.6 82.2%  
Return on capital %28.530.2 94.2%  
Exports to sales %00-   
Imports to sales %01.8 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA498 0.0%   
Fx inflow Rs m981,009 9.7%   
Fx outflow Rs m1498 0.1%   
Net fx Rs m97511 19.0%   
CASH FLOW
From Operations Rs m91-2,873 -3.2%  
From Investments Rs m-7714,701 -0.5%  
From Financial Activity Rs m-12-11,708 0.1%  
Net Cashflow Rs m3129 2.0%  

Share Holding

Indian Promoters % 71.1 68.0 104.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.9 -  
FIIs % 0.0 2.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.9 32.0 90.5%  
Shareholders   323 161,625 0.2%  
Pledged promoter(s) holding % 21.1 42.0 50.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ANG LIFESCIENCES INDIA With:   SUN PHARMA    LUPIN    CIPLA    DR. REDDYS LAB    AUROBINDO PHARMA    



Today's Market

Sensex Trades Marginally Lower as Auto Stocks Witness Selling; Maruti & Eicher Motors Fall 3%(10:30 am)

Asian stock markets are higher today, following the holiday in US markets, as economic recovery optimism returned to the fore.

Related Views on News

WOCKHARDT 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of WOCKHARDT for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of WOCKHARDT. Also includes updates on the valuation of WOCKHARDT.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ANG LIFESCIENCES INDIA SHARE PRICE


Jan 18, 2022 12:30 PM

TRACK ANG LIFESCIENCES INDIA

  • Track your investment in ANG LIFESCIENCES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ANG LIFESCIENCES INDIA

ANG LIFESCIENCES INDIA 8-QTR ANALYSIS

COMPARE ANG LIFESCIENCES INDIA WITH

MARKET STATS